Sagility India Limited · Valuation · TradingHolo

Sagility India Limited · Valuation · TradingHolo

Multiples

Shown only where the company is comparable with its peers

Multiple	Now	Sector median	Where it sits
P/E	23.4×	27.8×
Price / Book	2.2×	3.1×
Price / Sales	3.0×	3.0×
Price / Free cash flow	22.4×	−0.8×
EV / EBITDA	12.2×	17.4×
Earnings yield	4.3%	2.4%
Free cash flow yield	4.5%	0.0%	—

P/E at each quarterly report

Price at the report date ÷ trailing twelve-month earnings

No comparable valuation history is available.

Peers

Same market and sector · market cap in USD

Company	Price	Change	Mkt cap (USD)	P/E	ROE	1Y
NSE:SUNPHARMASun Pharmaceuticals Industries Ltd · 🇮🇳 NSE	₹1,758.80	−0.29%	$44.43B	36.8×	13.7%	+4.1%
NSE:DIVISLABDivi's Laboratories Ltd · 🇮🇳 NSE	₹9,144.50	+1.27%	$25.24B	93.5×	15.3%	+39.3%
NSE:TORNTPHARMTorrent Pharmaceuticals Ltd · 🇮🇳 NSE	₹4,558.90	−0.55%	$18.43B	81.0×	25.8%	+26.1%
NSE:APOLLOHOSPApollo Hospitals Enterprise Ltd · 🇮🇳 NSE	₹7,890.00	+0.01%	$12B	58.8×	20.5%	−1.0%
NSE:ZYDUSLIFEZydus Lifesciences Ltd · 🇮🇳 NSE	₹1,123.00	−1.51%	$11.97B	22.6×	18.6%	+11.3%
NSE:LAURUSLABSLaurus Labs Ltd · 🇮🇳 NSE	₹2,060.10	+2.06%	$11.48B	122.8×	16.8%	+123.0%
NSE:CIPLACipla Ltd · 🇮🇳 NSE	₹1,325.10	−0.22%	$11.33B	27.8×	11.3%	−19.5%
NSE:DRREDDYDr Reddy's Laboratories Ltd · 🇮🇳 NSE	₹1,233.00	+1.17%	$10.71B	23.8×	11.4%	−4.3%
NSE:MANKINDMankind Pharma Ltd · 🇮🇳 NSE	₹2,275.50	−3.07%	$10.23B	50.8×	11.7%	−7.0%
NSE:AUROPHARMAAurobindo Pharma Ltd · 🇮🇳 NSE	₹1,666.90	−0.66%	$10.14B	27.5×	9.2%	+51.5%